The canine cancer screening services market is projected to grow from USD 435.5 million in 2025 to USD 817.5 million by 2035, at a CAGR of 6.5%. Cut Biopsy will dominate with a 56.0% market share, while pet hospital will lead the application segment with a 60.0% share.